Featured Research

from universities, journals, and other organizations

Study Finds New Type Of Silicone Implant Offers More Natural Looking Breasts, Low Complication Rate

Date:
October 18, 2005
Source:
American Society of Plastic Surgeons
Summary:
A new type of silicone breast implant may offer breast augmentation and reconstruction patients more natural looking breasts with a low complication rate, according to a study in Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). The new gel implants will be the next type of silicone implant produced by manufacturers if the FDA approves the devices to be marketed and sold in the United States.

A new type of silicone breast implant, currently available to women whoagree to be part of a clinical study, offers breast augmentation andreconstruction patients more natural looking breasts with a lowcomplication rate, according to a recent study in Plastic andReconstructive Surgeryฎ, the official medical journal of the AmericanSociety of Plastic Surgeons (ASPS). The new gel implants will be thenext type of silicone implant produced by manufacturers if the U.S.Food and Drug Administration (FDA) approves the devices to be marketedand sold in the United States.

"It is an extreme understatement to say our patients are happy withthe more cohesive gel implants," said Mitchell Brown, MD, ASPS memberand study author. "These implants simply look and feel much morenatural than saline implants. My patients are thrilled with theirresults."

The new devices are more cohesive than those currently beingconsidered by the FDA. They have a gummy consistency, which allows themto hold their shape better than saline. According to the study, thegummy consistency decreases the likelihood of rippling and providesgreater safety because, being more solid, the silicone may not escapefrom the shell if it were to rupture. The more cohesive siliconematerial and its textured shell also give the implant a very naturaland proportionate breast shape.

"I think this is a great device," said Walter Erhardt, MD,chair of the ASPS Public Education Committee and surgeon participant inthe cohesive gel implant clinical study. "It's not perfect and there isgoing to be a learning curve for surgeons in terms of educating them onhow to use the more cohesive gel implants. A big criticism of previousimplants has been silent rupture and re-operation rates. In my opinion,this product has a good chance for a greater longevity rate as well asless complications."

According to the study, another benefit of the more cohesivegel implants is the availability of a wide variety of shapes and sizesto more closely match breast shapes and chest dimensions. For example,plastic surgeons can use a patient's breast measurements to customselect an implant specific to each breast.

Beyond the cosmetic advantages of the more cohesive implants, theseimplants have a low complication rate. In the study, only 3.4 percentof the 118 breast augmentation patients experienced complications,including hematoma, capsular contracture, and asymmetry. Nineteenpercent of the 32 breast reconstruction patients experiencedcomplications – most were minor with only one patient requiringre-operation. According to Dr. Brown, this rate of re-operation forbreast reconstruction patients is remarkably low considering theinherent challenges of breast reconstruction. He also noted that withan average follow-up of 21 months (ranging from 16 to 36 months),longer term data will be needed to further substantiate the promisingshort-term results.

"The more cohesive gel implants are going to play a major rolein aesthetic and reconstructive breast surgery if they are approved forsale in North America," said Dr. Brown. "We have already seen theirpotential through studies in Europe. Now, through our own research, weare finding with these implants, re-operation is rare, the complicationrate is low and patients are extremely pleased with their outcome."

According to the ASPS, more than 264,000 breast augmentations and nearly 63,000 breast reconstructions were performed in 2004.

The FDA is currently considering the reintroduction of siliconeimplants for sale in the United States, 13 year after it restrictedaccess to them due to safety concerns. In 1992, the FDA imposed amoratorium on the sale of silicone implants and saline implants havedominated the North American market. In the second half of 2005, afterthe manufacturers presented data at a panel hearing, the FDA issued"approval with conditions" for the sale of silicone implants,stipulating a number of conditions the manufacturers must satisfy inorder to receive FDA approval. Data regarding this new type of siliconeimplant, the more cohesive silicone implants, has not yet received anFDA panel hearing.

###

For referrals to ASPS Member Surgeons certified by the AmericanBoard of Plastic Surgery, call 888-4-PLASTIC (475-2784) or visit www.plasticsurgery.org where you can also learn more about cosmetic and reconstructive plastic surgery.

The American Society of Plastic Surgeons is the largest organization ofboard-certified plastic surgeons in the world. With more than 6,000members, the society is recognized as a leading authority andinformation source on cosmetic and reconstructive plastic surgery. ASPScomprises 94 percent of all board-certified plastic surgeons in theUnited States. Founded in 1931, the society represents physicianscertified by The American Board of Plastic Surgery or The Royal Collegeof Physicians and Surgeons of Canada.


Story Source:

The above story is based on materials provided by American Society of Plastic Surgeons. Note: Materials may be edited for content and length.


Cite This Page:

American Society of Plastic Surgeons. "Study Finds New Type Of Silicone Implant Offers More Natural Looking Breasts, Low Complication Rate." ScienceDaily. ScienceDaily, 18 October 2005. <www.sciencedaily.com/releases/2005/10/051018075542.htm>.
American Society of Plastic Surgeons. (2005, October 18). Study Finds New Type Of Silicone Implant Offers More Natural Looking Breasts, Low Complication Rate. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/10/051018075542.htm
American Society of Plastic Surgeons. "Study Finds New Type Of Silicone Implant Offers More Natural Looking Breasts, Low Complication Rate." ScienceDaily. www.sciencedaily.com/releases/2005/10/051018075542.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins